Advertisements
Advertisements
Question
How did an American Company, Eli Lilly use the knowledge of r-DNA technology to produce human insulin?
Advertisements
Solution
The structure of insulin consists of two short polypeptide chains chain A and chain B, linked together by disulphide bridges. In mammals, including human beings, insulin is synthesised as a pro-hormone, which contains an extra stretch called the C peptide, which is removed during maturation into insulin. The rDNA technique is used for assembling insulin into the mature form.
In 1983, Eli Lilly, an American company, prepared two DNA sequences corresponding to the A and B chains of human insulin and introduced them into the plasmids of E. coli to produce insulin chains. Chains A and B were produced separately, extracted and combined by creating disulphide bonds to form human insulin.
APPEARS IN
RELATED QUESTIONS
Explain enzyme – replacement therapy to treat adenosine deaminase deficiency. Mention two disadvantages of this procedure.
Recombination DNA−technology is of great importance in the field of medicine. With the help of a flow chart, show how this technology has been used in preparing genetically engineered human insulins.
Diagrammatically represent the experimental steps in cloning and expressing an human gene (say the gene for growth hormone) into a bacterium like E. coli?
The genetic defect adenosine deaminase deficiency may be cured permanently by ____________.
Mention the number of primers required in each cycle of PCR. Write the role of primers and DNA polymerase in PCR. Name the source organism of the DNA polymerase used in PCR.
What is genetically engineered Insulin?
If a person thinks he is infected with HIV, due to unprotected sex, and goes for a blood test. Do you think a test such as ELISA will help? If so why? If not, why?
C-peptide of human insulin is ______.
A pathophysiology is the ______.
When gene targetting involving gene amplification is attempted in an individual’s tissue to treat disease, it is known as ______
With regard to insulin choose the correct options.
- C-peptide is not present in mature insulin.
- The insulin produced by rDNA technology has C-peptide.
- The pro-insulin has C-peptide.
- A-peptide and B-peptide of insulin are interconnected by disulphide bridges.
Choose the correct answer from the options given below.
Give the full form of ELISA. Which disease can be detected using it? Discuss the principle underlying the test.
Can a disease be detected before its symptoms appear? Explain the principle involved.
When a foreign DNA is introduced into an organism, how is it maintained in the host and how is it transferred to the progeny of the organism?
A patient is suffering from ADA deficiency. Can he be cured? How?
Name the five key tools for accomplishing the tasks of recombinant DNA technology. Also mention the functions of each tool.
How does a gene therapy involving direct modification of the cells, in order to achieve a therapeutic goal is used in the treatment of ADA deficiency? Explain.
Explain how recombinant human insulin was prepared in 1983 by Eli Lily an American company.
